MENU
BMEA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Biomea Fusion (BMEA) Earnings Date & Reports

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more

A.I. Advisor
published Earnings

BMEA is expected to report earnings to fall 32.47% to -34 cents per share on November 04

Biomea Fusion BMEA Stock Earnings Reports
Q3'25
Est.
$-0.34
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.03
The last earnings report on August 05 showed earnings per share of -50 cents, beating the estimate of -54 cents. With 387.66K shares outstanding, the current market capitalization sits at 91.64M.
View a ticker or compare two or three
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMEA showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com